National Drug Control Policy Office 2021 – Federal Register Recent Federal Regulation Documents

Appointment of Members of Senior Executive Service Performance Review Board
Document Number: 2021-16167
Type: Notice
Date: 2021-07-29
Agency: Executive Office of the President, National Drug Control Policy Office
The following persons have been appointed to the ONDCP Senior Executive Service Performance Review Board: Ms. Martha Gagn[eacute] (as Chair), Mr. Kemp Chester, Mr. Eric Talbot, and Ms. Michele Marx.
Application of Equity in U.S. National Drug Control Policy
Document Number: 2021-14365
Type: Notice
Date: 2021-07-07
Agency: Executive Office of the President, National Drug Control Policy Office
The Office of National Drug Control Policy (ONDCP) is seeking comments from the public on whether and to what extent ONDCP's policy development process, drug budget review and certification processes of the 18 National Drug Control Program Agencies, and Grant Administration Programs perpetuate systemic barriers to opportunities for underserved communities and individuals from those communities. ONDCP is also seeking comments from the public regarding how its future proposed policies, budgets, regulations, grants, or programs might be more effective in advancing equity.
Designation of Six Areas as High Intensity Drug Trafficking Areas
Document Number: 2021-10852
Type: Notice
Date: 2021-05-24
Agency: Executive Office of the President, National Drug Control Policy Office
The Director of the Office of National Drug Control Policy designated six additional areas as High Intensity Drug Trafficking Areas (HIDTA).. The new areas are (1) Daviess County in Kentucky as part of the Appalachia HIDTA; (2) El Dorado and Placer Counties in California as part of the Central Valley California HIDTA; (3) Madison and St. Clair Counties in Illinois as part of the Midwest HIDTA; and (4) Erie County in Pennsylvania as part of the Ohio HIDTA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.